Osborne Clarke has advised Creo Medical Group PLC. Creo Medical Group PLC (” Creo “), an AIM-quoted medical devices company focusing on the emerging field of...
Creo Medical Group PLC’s £33.7 Million Fundraise
Creo Medical Group’s £36 Million Fundraising
Osborne Clarke has advised Creo Medical Group on the deal. Creo Medical Group, a medical device company focused on the emerging field of surgical endoscopy, quoted...